154 related articles for article (PubMed ID: 1913297)
1. Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients.
Montemurro L; Schiraldi G; Fraioli P; Tosi G; Riboldi A; Rizzato G
Calcif Tissue Int; 1991 Aug; 49(2):71-6. PubMed ID: 1913297
[TBL] [Abstract][Full Text] [Related]
2. Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis.
Rizzato G; Tosi G; Schiraldi G; Montemurro L; Zanni D; Sisti S
Sarcoidosis; 1988 Sep; 5(2):99-103. PubMed ID: 3227195
[TBL] [Abstract][Full Text] [Related]
3. Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study.
Luengo M; Pons F; Martinez de Osaba MJ; Picado C
Thorax; 1994 Nov; 49(11):1099-102. PubMed ID: 7831624
[TBL] [Abstract][Full Text] [Related]
4. Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis.
Adachi JD; Bensen WG; Bell MJ; Bianchi FA; Cividino AA; Craig GL; Sturtridge WC; Sebaldt RJ; Steele M; Gordon M; Themeles E; Tugwell P; Roberts R; Gent M
Br J Rheumatol; 1997 Feb; 36(2):255-9. PubMed ID: 9133941
[TBL] [Abstract][Full Text] [Related]
5. Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients.
Gonnelli S; Rottoli P; Cepollaro C; Pondrelli C; Cappiello V; Vagliasindi M; Gennari C
Calcif Tissue Int; 1997 Nov; 61(5):382-5. PubMed ID: 9351879
[TBL] [Abstract][Full Text] [Related]
6. Prednisone-induced bone loss in sarcoidosis: a risk especially frequent in postmenopausal women.
Rizzato G; Tosi G; Mella C; Montemurro L; Zanni D; Sisti S
Sarcoidosis; 1988 Sep; 5(2):93-8. PubMed ID: 3227194
[TBL] [Abstract][Full Text] [Related]
7. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
[TBL] [Abstract][Full Text] [Related]
8. [Use of salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis in bullous diseases].
Cappio F; Colombo MD; Caputo R
G Ital Dermatol Venereol; 1990 Dec; 125(12):LXI-LXIV. PubMed ID: 2091976
[TBL] [Abstract][Full Text] [Related]
9. The effect of intranasal salmon calcitonin therapy on bone mineral density in idiopathic male osteoporosis without vertebral fractures--an open label study.
Tóth E; Csupor E; Mészáros S; Ferencz V; Németh L; McCloskey EV; Horváth C
Bone; 2005 Jan; 36(1):47-51. PubMed ID: 15664001
[TBL] [Abstract][Full Text] [Related]
10. Natural and corticosteroid-induced osteoporosis in sarcoidosis: prevention, treatment, follow up and reversibility.
Rizzato G; Fraioli P
Sarcoidosis; 1990 Sep; 7(2):89-92. PubMed ID: 2255799
[No Abstract] [Full Text] [Related]
11. Analgesic effect of intranasal and intramuscular salmon calcitonin in post-menopausal osteoporosis: a double-blind, double-placebo study.
Pontiroli AE; Pajetta E; Scaglia L; Rubinacci A; Resmini G; Arrigoni M; Pozza G
Aging (Milano); 1994 Dec; 6(6):459-63. PubMed ID: 7748920
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
Kapetanakis EI; Antonopoulos AS; Antoniou TA; Theodoraki KA; Zarkalis DA; Sfirakis PD; Chilidou DA; Alivizatos PA
J Heart Lung Transplant; 2005 May; 24(5):526-32. PubMed ID: 15896748
[TBL] [Abstract][Full Text] [Related]
13. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512
[TBL] [Abstract][Full Text] [Related]
14. Bone loss in prednisone treated sarcoidosis: a two-year follow-up.
Montemurro L; Fraioli P; Riboldi A; Delpiano S; Zanni D; Rizzato G
Ann Ital Med Int; 1990; 5(3 Pt 1):164-8. PubMed ID: 2288818
[TBL] [Abstract][Full Text] [Related]
15. Researching osteoporosis in prednisone treated sarcoid patients.
Rizzato G; Tosi G; Mella C; Zanni D; Sisti S; Loglisci T
Sarcoidosis; 1987 Mar; 4(1):45-8. PubMed ID: 3589192
[TBL] [Abstract][Full Text] [Related]
16. An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss.
Gennari C; Agnusdei D; Montagnani M; Gonnelli S; Civitelli R
Calcif Tissue Int; 1992 Apr; 50(4):381-3. PubMed ID: 1571851
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers.
Trovas GP; Lyritis GP; Galanos A; Raptou P; Constantelou E
J Bone Miner Res; 2002 Mar; 17(3):521-7. PubMed ID: 11874243
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cyclic and continuous calcitonin regimens in the treatment of postmenopausal osteoporosis.
Tekeoğlu I; Adak B; Budancamanak M; Demirel A; Ediz L
Rheumatol Int; 2005 Dec; 26(2):157-61. PubMed ID: 15660234
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
[TBL] [Abstract][Full Text] [Related]
20. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
